Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

The Most Famous Artist Mints First NFT from Human Fecal Matter to Fund Gut-Brain Research Grant

This image opens in the lightbox

News provided by

Seed Health

29 Jun, 2021, 10:00 GMT

Share this article

Share toX

Share this article

Share toX

LOS ANGELES, June 29, 2021 /PRNewswire/ -- The Most Famous Artist, Matty Mo, infamous for his studio's part in the monolith stunt in 2020, has dropped "The Most Sh*ttiest NFT", the first non-fungible token (NFT) made with human fecal matter (his own, to be exact). Minted on OpenSea, this edition of one is a 360 degree video capture of an FMT¹ "crapsule" encased in a museum-quality glass cube auctioned as an NFT paired with the physical sculpture. Commissioned by microbial sciences company, Seed Health, all proceeds of the NFT will fund a gut-brain research grant for autism spectrum disorder (ASD). Grant recipients will be selected by world-renowned microbiome researchers, Sarkis Mazmanian, Ph.D. and Christopher Mason, Ph.D.

Continue Reading
This image opens in the lightbox
The Most Sh*ttiest NFT 3-D
This image opens in the lightbox
The Most Sh*ttiest NFT
This image opens in the lightbox
The Most Famous Artist Mints First NFT from Human Fecal Matter to Fund Gut-Brain Research Grant
This image opens in the lightbox
The Most Famous Artist

"From Piero Manzoni to Chris Ofili and Andres Serrano, the use of human biomass in art has long sparked controversy around what should be considered "art," and consequently, what is valuable. Today, NFTs are now in the cross hairs of this value system, disrupting a market that has been reserved for the curated few," quipped Matty Mo. "By taking the taboo topic of human excrement and assigning it value, we are sending an important message that the very things that disgust us, may actually be what's most valuable—in this case, for the future of health."

As the science of stool has advanced, microbiome research is expanding beyond the gut and gastrointestinal (GI) conditions to this new frontier of the gut-brain axis—the communication between the GI tract, our gut microbiome, and the central nervous system.

"Our work demonstrates that stool is so much more than waste. It is a diagnostic tool containing microbial, chemical, physiological and functional indicators of human health," stated Dr. Christopher Mason. "Decoding the components of stool helps us understand the behaviors and prevalence of diseases such as cancers, Alzheimer's disease, Parkinson's disease, even ASD, further illuminating the interwoven relationship between our gut microbiome and brain." 

Human 'poop' is also now prospected for its therapeutic potential. For example, FMT, or Fecal Microbiota Transplant, takes a microbial sample from the stool of a healthy donor and administers it to individuals suffering from certain diseases. New FMT research has also shown promise in dramatically improving behavior and gut symptoms among children with ASD.2  

"This NFT draws attention to a new and disruptive view of medicine: that cures are already inside of us, optimized by nature and evolution. The funds from the NFT will go a long way in pushing the frontiers of biomedical research, particularly in ASD, toward microbiome-derived approaches such as FMTs that optimize health," stated Dr. Mazmanian.

"We are now at a critical inflection point in gut-brain research. With new mechanistic discoveries in this field, we can move beyond correlation and characterize the critical functions microbes perform and how we may harness specific strains to develop breakthrough treatments for neuropsychiatric and neurodevelopmental conditions," stated Raja Dhir, Seed Health co-founder and co-CEO. 

As part of its mission to pioneer new microbial applications, Seed Health has created provocative moments to engage the public and propel the microbiome into the zeitgeist with award-winning campaigns like the 2020 #GIVEASHIT Citizen Science initiative, which successfully crowdsourced the world's first and largest database of stool images for use in academic research and in the development of novel digital health tools. 

"Inspired by the disruptive spirit of the NFT community, we want to ignite a dialogue around this new frontier of gut-brain research," stated Ara Katz, Seed Health co-founder and co-CEO. "We hope this inspires new opportunities for art to catalyze broader public engagement with areas of science that have the potential to impact the health of millions globally." 

The Most Sh*ttiest NFT will be offset using Aerial, a sustainability platform that sums the Ethereum gas used and calculates the carbon emissions based on the associated energy use. The net estimate for offsets is 15-20 tonnes, which Seed Health and Aerial will round to 25 tonnes for any future reselling, wallet transfers, and to maintain carbon negativity.

•

Disclaimer: Should you experience disgust, hatred, or confirmation bias, kindly close your browser. However, should you experience symptoms of perspective shifting, questioning, or a wry smile in the face of irony, congratulations—the world needs more humans like you.

themostshittiestnft.com 
#TheMostShittiestNFT #GiveAShit

•

¹ Kang, D. W., Adams, J. B., Coleman, D. M., Pollard, E. L., Maldonado, J., McDonough-Means, S., Caporaso, J. G., & Krajmalnik-Brown, R. (2019). Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota. Scientific reports, 9(1), 5821. https://doi.org/10.1038/s41598-019-42183-0

2 Svoboda, E. Could the Gut Microbiome Be Linked to Autism? Nature, vol. 577, no. 7792, 2020, doi:10.1038/d41586-020-00198-y

About "The Most Shittiest NFT"
The first NFT (Non-Fungible Token) made from human fecal matter (C₉H₉N, containing ~10⁸ Bacteria; Various Strains). The physical cube sculpture was biologically excavated by Matty Mo (The Most Famous Artist), lyophilized into powder, nested within Silicone Dioxide (SiO₂), and set inside a gelatin FMT (Fecal Microbiota Transplant) "crapsule" by Flora Medicine. The capsule is cast and suspended in layers of glass. The sculpture measures 177.8 millimeters in width and height, and weighs 14.968 kilograms. To produce the digital art, the physical glass cube sculpture was video captured on a 360-degree single-axis table, and rendered and rotoscoped in 4D. It is digitally minted as a 1-of-1 edition on the Etherium (ETH) blockchain and carbon offset with Aerial (approximately 20-25 tonnes). All proceeds will fund a gut-brain axis research grant for autism spectrum disorder (ASD).

About "The Most Famous Artist"
Matty Mo is a New Mexico-based artist and entrepreneur best known for creating the social token-powered global community known as "The Most Famous Artist." Together they create large-scale headline-generating spectacles and are working on helping 10,000 artists achieve financial freedom independent of institutional gatekeepers. themostfamousartist.com

About Seed Health
Seed Health is a microbial sciences company pioneering applications of microbes for human and planetary health. In collaboration with leading academic researchers, we advance breakthrough discoveries in microbial science across a pipeline of novel therapeutics, consumer health innovations and environmental solutions. All consumer innovations in probiotics are commercialized under Seed®. seedhealth.com / seed.com

About Aerial 
Aerial is a sustainability platform that empowers people to take climate action and reduce their carbon footprint across NFTs, transportation, and other emissions sources. Aerial tracks your emissions, gives you simple ways to take action, and offers exclusive insights from credible science writers on how to live more sustainably. Aerial makes climate action easy and fun. aerial.is

Video - https://mma.prnewswire.com/media/1553857/The_Most_Sh_ttiest_NFT_3_D.mp4
Photo - https://mma.prnewswire.com/media/1553838/Hero_Static.jpg
Photo - https://mma.prnewswire.com/media/1553841/QR_CODE_the_most_sh_ttiest_nft_com.jpg
Photo - https://mma.prnewswire.com/media/1553839/TMFA_Signature.jpg
Logo - https://mma.prnewswire.com/media/1553840/Seed_Logo.jpg  

Related Links

https://www.seedhealth.com/

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.